Dr. Suzanne Craft
Claim this profileWake Forest University Health Sciences
Studies Mild Cognitive Impairment
Studies Alzheimer's Disease
9 reported clinical trials
12 drugs studied
Affiliated Hospitals
Clinical Trials Suzanne Craft is currently running
CT1812
for Early Alzheimer's Disease
This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's disease.
Recruiting0 awards Phase 2
Ketogenic Diet vs Low-Fat Diet
for Alzheimer's Disease
The Brain Energy for Amyloid Transformation in AD (Alzheimer's disease) or BEAT-AD study will compare the effects of a ketogenic low-carbohydrate diet and a low-fat diet in adults with mild cognitive impairment. The data collected will help determine whether diet interventions induce changes in cognitive function, cerebral blood flow, and levels of certain proteins and hormones in body fluids. The study will include volunteers who have mild cognitive impairment, who will be randomly assigned to receive either a ketogenic low-carbohydrate diet or a low-fat diet for 16-weeks, with follow-up assessment 8 weeks after diet completion. Study measures, clinic visits and phone sessions will occur at baseline and throughout the 24-week study. Group 2 will include volunteers who have mild cognitive impairment. This group will complete a 16-week low-fat diet study, with follow-up assessment 8 weeks after diet final completion. Study measures, clinic visits and phone sessions will occur throughout the 24-week study. Participant will follow either a low-carbohydrate or low-fat diet that will be individually planned with help from a study dietitian. After completing the study diet for 16 weeks, participants will resume their normal diet. The final visits will occur at week 24 (8 weeks after the completing the diet). At the end of the 24-week study, participants will be given the opportunity to meet with the study dietitian for education and assistance with planning a healthy diet.
Recruiting1 award N/A
More about Suzanne Craft
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Suzanne Craft has experience with
- Senolytic Therapy
- Low-carbohydrate/High-fat Diet
- Low-fat/High-carbohydrate Diet
- Intranasal Insulin
- Metformin
- CT1812
Breakdown of trials Suzanne Craft has run
Mild Cognitive Impairment
Alzheimer's Disease
Cognitive Impairment
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Suzanne Craft specialize in?
Suzanne Craft focuses on Mild Cognitive Impairment and Alzheimer's Disease. In particular, much of their work with Mild Cognitive Impairment has involved treating patients, or patients who are undergoing treatment.
Is Suzanne Craft currently recruiting for clinical trials?
Yes, Suzanne Craft is currently recruiting for 2 clinical trials in Winston-Salem North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Suzanne Craft has studied deeply?
Yes, Suzanne Craft has studied treatments such as Senolytic Therapy, Low-carbohydrate/High-fat Diet, Low-fat/High-carbohydrate Diet.
What is the best way to schedule an appointment with Suzanne Craft?
Apply for one of the trials that Suzanne Craft is conducting.
What is the office address of Suzanne Craft?
The office of Suzanne Craft is located at: Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157 United States. This is the address for their practice at the Wake Forest University Health Sciences.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.